tradingkey.logo
tradingkey.logo
Search

Niagen Bioscience Inc

NAGE
Add to Watchlist
3.430USD
+0.100+3.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
273.42MMarket Cap
14.69P/E TTM

Niagen Bioscience Inc

3.430
+0.100+3.00%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+3.00%

5 Days

+0.29%

1 Month

-2.00%

6 Months

-45.12%

Year to Date

-46.07%

1 Year

-73.01%

Key Figures
3.350Open
3.445High
464.71KVolume
14.69P/E TTM
10.77P/E Dynamic
--Dividend TTM
0.58%Turnover Ratio
3.330Prev. Close
3.350Low
1.12MTurnover
31.98P/E Static
3.57P/B
0.00%Div Yield TTM
19.05%ROA
14.69052wk High
0.85Volume Ratio
8.55MNet Profit
79.71MShares
0.2335EPS TTM
2.19Beta
27.07%ROE
4.16052wk Low
2.85%Amplitude
63.47%Gross Margin
273.42MMarket Cap
-1.60Reward/Risk
3.03%Risk Rate

Key Insights

Niagen Bioscience Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 46 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.60.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Niagen Bioscience Inc's Score

Industry at a Glance

Industry Ranking
46 / 387
Overall Ranking
132 / 4565
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Niagen Bioscience Inc Highlights

StrengthsRisks
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 54.87% year-on-year.
Fairly Valued
The company’s latest PE is 14.69, at a medium 3-year percentile range.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 9.36K shares of this stock.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
12.600
Target Price
+278.38%
Upside Space

Niagen Bioscience Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Niagen Bioscience Inc Info

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
Ticker SymbolNAGE
CompanyNiagen Bioscience Inc
CEOFried (Robert N)
Websitehttps://www.niagenbioscience.com/

FAQs

What is the current price of Niagen Bioscience Inc (NAGE)?

The current price of Niagen Bioscience Inc (NAGE) is 3.43.

What is the symbol of Niagen Bioscience Inc?

The ticker symbol of Niagen Bioscience Inc is NAGE.

What is the 52-week high of Niagen Bioscience Inc?

The 52-week high of Niagen Bioscience Inc is 14.69.

What is the 52-week low of Niagen Bioscience Inc?

The 52-week low of Niagen Bioscience Inc is 4.16.

What is the market capitalization of Niagen Bioscience Inc?

The market capitalization of Niagen Bioscience Inc is 273.42M.

Is Niagen Bioscience Inc (NAGE) currently rated as Buy, Hold, or Sell?

According to analysts, Niagen Bioscience Inc (NAGE) has an overall rating of Buy, with a price target of 12.60.

What is the Earnings Per Share (EPS TTM) of Niagen Bioscience Inc (NAGE)?

The Earnings Per Share (EPS TTM) of Niagen Bioscience Inc (NAGE) is 0.22.